SINGAPORE: All seven insurers providing Integrated Shield Plans are extending their protection of hospitalisation ensuing from COVID-19 vaccine problems to embody vaccines brought in under the special access route, such because the Sinovac jab.
This will apply to policyholders who obtain COVID-19 vaccines which can be authorised by the World Health Organization (WHO) under its emergency use itemizing and administered in Singapore under the special access route, mentioned the Life Insurance Association, Singapore (LIA Singapore).
The further protection shall be offered till Dec 31, mentioned the affiliation on Thursday (Jun 17).
It added that it’s going to work with insurers for any consideration of extensions to the length of protection, alongside monitoring the evolving COVID-19 state of affairs.
READ: ‘Overwhelming’ response for Sinovac COVID-19 vaccine at some authorised clinics
Currently, solely the Sinovac vaccine is run under the special access route, which permits personal healthcare establishments to carry in unregistered COVID-19 vaccines.
Vaccines brought in under the special access route have to be on the WHO’s emergency use itemizing. The itemizing additionally consists of photographs by Johnson & Johnson, AstraZeneca and Sinopharm.
READ: Days off, free medical consultations: Companies roll out assist for staff taking COVID-19 vaccine
Hospitalisation for problems arising from the Pfizer-BioNTech and Moderna vaccines, which have been authorised by Singapore’s Health Sciences Authority and are a part of the nation’s nationwide inoculation programme, is already coated under Integrated Shield Plans. Both are messenger RNA (mRNA) vaccines.
“We understand that some Singaporeans may wish to receive vaccination under (the special access route) and hope that our member insurers’ proactive commitment in extending inpatient hospitalisation benefits for complications can provide assurance that such (Integrated Shield Plan) policyholders will be covered,” mentioned LIA Singapore president Khor Hock Seng.
READ: 24 clinics chosen to administer Sinovac COVID-19 vaccine; S$10 to S$25 for single dose
The Sinovac jab, an inactivated virus vaccine, is free for those that have been beforehand rejected from taking the mRNA vaccines due to extreme allergic reactions or allergic reactions to the primary dose. Others preferring the Sinovac vaccine for non-medical causes pay an administrative price to the personal healthcare suppliers.
Those who take the Sinovac vaccine should not coated under the Vaccine Injury Financial Assistance Programme for COVID-19 Vaccination.
Integrated Shield Plans are made up of two parts – MediShield Life run by the Central Provident Fund Board and an extra personal insurance coverage protection part run by insurance coverage corporations. The latter covers hospitalisation in A- and B1-type wards in public hospitals in addition to personal hospitals.
Insurers providing Integrated Shield Plans are: AIA, Aviva, AXA, Great Eastern Life, NTUC Income, Prudential and Raffles Health Insurance.
BOOKMARK THIS: Our complete protection of the COVID-19 pandemic and its developments
Download our app or subscribe to our Telegram channel for the most recent updates on the coronavirus outbreak: https://cna.asia/telegram
